adplus-dvertising
Connect with us

Business

Covid: Australia hopes to roll out almost 85 million vaccine doses – BBC News

Published

 on



.css-94m6rd-HeadingWrapperborder-bottom:solid 1px #BABABA;padding-bottom:1.5rem;.css-94m6rd-HeadingWrapper > *:not([hidden]):not(style) ~ *:not([hidden]):not(style)margin-top:1rem;

.css-1c1994u-StyledHeadingfont-family:ReithSerif,Helvetica,Arial,freesans,sans-serif;font-weight:500;font-size:2rem;line-height:2.25rem;color:#3F3F42;@media (min-width:37.5rem).css-1c1994u-StyledHeadingfont-size:2.75rem;line-height:3rem;.css-1c1994u-StyledHeading:focusoutline-style:none;.css-1c1994u-StyledHeading:focus-visibleoutline-style:auto;

.css-11c8au8-MetadataStripfont-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.8125rem;line-height:1rem;margin-top:-0.25rem;color:#696969;

.css-8d0yke-MetadataStripItemdisplay:inline-block;white-space:nowrap;margin-top:0.25rem;max-width:calc(100% – 1em);.css-8d0yke-MetadataStripItem::aftercontent:”;display:inline-block;height:1.25em;border-left:#BABABA 1px solid;margin:0 0.5em;vertical-align:-0.25em;.css-8d0yke-MetadataStripItem:last-childmax-width:100%;.css-8d0yke-MetadataStripItem:last-child::aftercontent:none;

.css-r83t2i-ComponentWrappermargin:1.5rem 0;

.css-1759m9z-StyledFigurefont-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.875rem;line-height:1.125rem;

.css-kwaqyc-StyledFigureContainerposition:relative;

.css-9abvm1-Placeholderposition:relative;display:block;padding-bottom:56.25%;background-color:#EEEEEE;.css-9abvm1-Placeholder > imgoverflow:hidden;position:absolute;top:0;right:0;bottom:0;left:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;width:100%;height:100%;object-fit:cover;

.css-evoj7m-Imagedisplay:block;width:100%;height:auto;

.css-1ecljvk-StyledFigureCopyrightposition:absolute;bottom:0;right:0;background:#3F3F42;color:#EEEEEE;padding:0.25rem 0.5rem;text-transform:uppercase;image copyrightGetty Images

.css-1rnnz6t-StyledFigureCaptionbackground:#3F3F42;color:#EEEEEE;padding:1rem;

.css-uf6wea-RichTextComponentWrappermargin:1rem 0;max-width:36.25rem;

.css-83cqas-RichTextContainercolor:#3F3F42;.css-83cqas-RichTextContainer > *:not([hidden]):not(style) ~ *:not([hidden]):not(style)margin-top:1rem;

.css-14iz86j-BoldTextfont-weight:bold;Australia says it will secure almost 85 million doses of a coronavirus vaccine if two promising trials prove successful.

Prime Minister Scott Morrison said the country had struck two deals that would allow free doses to be rolled out in 2021 if they were approved for use.

Mr Morrison estimated the cost to be A$1.7bn (£0.9bn; $1.24bn).

Australia’s 25 million people could begin receiving doses from January but there were “no guarantees”, he said.

“However the agreement puts Australia at the top of the queue, if our medical experts give the vaccines the green light,” the prime minister said.

One vaccine is from Oxford University and pharmaceutical company AstraZeneca, while the other is a local one from the University of Queensland and CSL.

.css-1pzprxn-BulletListContainermargin-left:1.5rem;.css-1pzprxn-BulletListContainer *:not([hidden]):not(style) ~ *:not([hidden]):not(style)margin-top:1rem;.css-1pzprxn-BulletListContainer ullist-style-type:disc;.css-1pzprxn-BulletListContainer ollist-style-type:decimal;

  • .css-yidnqd-InlineLink:linkcolor:#3F3F42;.css-yidnqd-InlineLink:visitedcolor:#696969;.css-yidnqd-InlineLink:link,.css-yidnqd-InlineLink:visitedfont-weight:bolder;border-bottom:1px solid #BABABA;-webkit-text-decoration:none;text-decoration:none;.css-yidnqd-InlineLink:link:hover,.css-yidnqd-InlineLink:visited:hover,.css-yidnqd-InlineLink:link:focus,.css-yidnqd-InlineLink:visited:focusborder-bottom-color:currentcolor;border-bottom-width:2px;color:#B80000;@supports (text-underline-offset:0.25em).css-yidnqd-InlineLink:link,.css-yidnqd-InlineLink:visitedborder-bottom:none;-webkit-text-decoration:underline #BABABA;text-decoration:underline #BABABA;-webkit-text-decoration-thickness:1px;text-decoration-thickness:1px;-webkit-text-decoration-skip-ink:none;text-decoration-skip-ink:none;text-underline-offset:0.25em;.css-yidnqd-InlineLink:link:hover,.css-yidnqd-InlineLink:visited:hover,.css-yidnqd-InlineLink:link:focus,.css-yidnqd-InlineLink:visited:focus-webkit-text-decoration-color:currentcolor;text-decoration-color:currentcolor;-webkit-text-decoration-thickness:2px;text-decoration-thickness:2px;color:#B80000;UK signs deal for 60 million virus vaccine doses
  • How close to developing a vaccine are we?

Australia has recorded more than 26,000 coronavirus cases and 769 deaths, most in the past two months after an outbreak in Victoria.

The state announced on Sunday it was extending its strict lockdown for another two weeks, before gradually easing restrictions.

Under the plan, people in Melbourne will not be able to visit other households for group gatherings until at least late November.

.css-72p885-ComponentWrapper-CrossheadComponentWrappermargin:1.5rem 0;padding-top:1rem;

.css-1jlqpzd-StyledHeadingfont-family:ReithSerif,Helvetica,Arial,freesans,sans-serif;font-weight:500;font-size:1.5rem;line-height:1.75rem;color:#3F3F42;@media (min-width:37.5rem).css-1jlqpzd-StyledHeadingfont-size:2rem;line-height:2.25rem;.css-1jlqpzd-StyledHeading:focusoutline-style:none;.css-1jlqpzd-StyledHeading:focus-visibleoutline-style:auto;

Vaccines to be produced in Australia

Most of the vaccines would be manufactured in Australia in line with previous promises, the government said.

The nation has agreements for 33.8 million doses of the Oxford vaccine and 51 million doses of a UQ vaccine, reported the Australian Broadcasting Corporation.

Early access to the Oxford vaccine – if it is found to work – could begin in January and February with 3.8 million doses secured for that period.

Vaccine trial at Oxford University

image copyrightUniversity of Oxford

That vaccine is in phase three of clinical trials and is being tested on 30,000 people. Australia announced last month it had secured access to it.

The UQ/CSL vaccine is in phase one of clinical trials, involving tests on a small control group.

The Australian government has said that immunisation won’t be compulsory but strongly encouraged. The nation is aiming for a 95% vaccination rate.

Mr Morrison said Australia also remained committed to ensure vaccine access for its neighbours in the Pacific and South East Asia.

Countries around the world have been scrambling to arrange deals for potential vaccines, prompting concerns that poorer nations may miss out.

In July, the World Health Organization said 165 countries had signed up to a fund which would see wealthier nations help poorer nations with access.

About 140 potential vaccines globally are in early development, and dozens are being tested on people in clinical trials.

.css-144ki52-SectionWrappermargin:1.5rem 0;padding-top:1.5rem;

.css-2yhany-StyledTagContainerfont-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.875rem;line-height:1.125rem;

.css-4c4zzp-SectionHeaderWrappermargin-bottom:1.5rem;

.css-17tl22c-SectionHeaderborder-top:0.125rem solid #B80000;padding-top:0.75rem;@media (min-width:37.5rem).css-17tl22c-SectionHeaderpadding-top:1rem;

.css-5h2rh7-StyledHeadingfont-family:ReithSerif,Helvetica,Arial,freesans,sans-serif;font-weight:500;font-size:1.125rem;line-height:1.375rem;color:#3F3F42;@media (min-width:37.5rem).css-5h2rh7-StyledHeadingfont-size:1.25rem;line-height:1.5rem;.css-5h2rh7-StyledHeading:focusoutline-style:none;.css-5h2rh7-StyledHeading:focus-visibleoutline-style:auto;

Related Topics

.css-1emjddl-Clusteroverflow:hidden;

.css-1oubwgi-ClusterItemsdisplay:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;margin:calc(0.5rem / 2 * -1);.css-1oubwgi-ClusterItems > *margin:calc(0.5rem / 2);

    .css-dh1p3g-StyledTagdisplay:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;white-space:nowrap;

  • .css-1sd1v8r-StyledLinkcolor:#3F3F42;border:1px solid #DB7F7F;font-weight:bold;padding:0.5rem;-webkit-text-decoration:none;text-decoration:none;.css-1sd1v8r-StyledLink:hover,.css-1sd1v8r-StyledLink:focusbackground:#B80000;color:#FFFFFF;Australia

More on this story

    .css-1as76fj-PromoItemmargin:1.5rem 0;

  • .css-mbfif2-Promofont-family:ReithSans,Helvetica,Arial,freesans,sans-serif;font-weight:400;font-size:0.875rem;line-height:1.125rem;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;position:relative;background:#FFFFFF;outline:solid transparent;color:#696969;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;height:100%;false;.css-mbfif2-Promo .ett16tt0-webkit-flex:none;-ms-flex:none;flex:none;margin-bottom:0.5rem;.css-mbfif2-Promo .ett16tt9-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;.css-mbfif2-Promo a:not(.ett16tt7)z-index:2;position:relative;

Let’s block ads! (Why?)

728x90x4

Source link

Business

Japan’s SoftBank returns to profit after gains at Vision Fund and other investments

Published

 on

 

TOKYO (AP) — Japanese technology group SoftBank swung back to profitability in the July-September quarter, boosted by positive results in its Vision Fund investments.

Tokyo-based SoftBank Group Corp. reported Tuesday a fiscal second quarter profit of nearly 1.18 trillion yen ($7.7 billion), compared with a 931 billion yen loss in the year-earlier period.

Quarterly sales edged up about 6% to nearly 1.77 trillion yen ($11.5 billion).

SoftBank credited income from royalties and licensing related to its holdings in Arm, a computer chip-designing company, whose business spans smartphones, data centers, networking equipment, automotive, consumer electronic devices, and AI applications.

The results were also helped by the absence of losses related to SoftBank’s investment in office-space sharing venture WeWork, which hit the previous fiscal year.

WeWork, which filed for Chapter 11 bankruptcy protection in 2023, emerged from Chapter 11 in June.

SoftBank has benefitted in recent months from rising share prices in some investment, such as U.S.-based e-commerce company Coupang, Chinese mobility provider DiDi Global and Bytedance, the Chinese developer of TikTok.

SoftBank’s financial results tend to swing wildly, partly because of its sprawling investment portfolio that includes search engine Yahoo, Chinese retailer Alibaba, and artificial intelligence company Nvidia.

SoftBank makes investments in a variety of companies that it groups together in a series of Vision Funds.

The company’s founder, Masayoshi Son, is a pioneer in technology investment in Japan. SoftBank Group does not give earnings forecasts.

___

Yuri Kageyama is on X:

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Trump campaign promises unlikely to harm entrepreneurship: Shopify CFO

Published

 on

 

Shopify Inc. executives brushed off concerns that incoming U.S. President Donald Trump will be a major detriment to many of the company’s merchants.

“There’s nothing in what we’ve heard from Trump, nor would there have been anything from (Democratic candidate) Kamala (Harris), which we think impacts the overall state of new business formation and entrepreneurship,” Shopify’s chief financial officer Jeff Hoffmeister told analysts on a call Tuesday.

“We still feel really good about all the merchants out there, all the entrepreneurs that want to start new businesses and that’s obviously not going to change with the administration.”

Hoffmeister’s comments come a week after Trump, a Republican businessman, trounced Harris in an election that will soon return him to the Oval Office.

On the campaign trail, he threatened to impose tariffs of 60 per cent on imports from China and roughly 10 per cent to 20 per cent on goods from all other countries.

If the president-elect makes good on the promise, many worry the cost of operating will soar for companies, including customers of Shopify, which sells e-commerce software to small businesses but also brands as big as Kylie Cosmetics and Victoria’s Secret.

These merchants may feel they have no choice but to pass on the increases to customers, perhaps sparking more inflation.

If Trump’s tariffs do come to fruition, Shopify’s president Harley Finkelstein pointed out China is “not a huge area” for Shopify.

However, “we can’t anticipate what every presidential administration is going to do,” he cautioned.

He likened the uncertainty facing the business community to the COVID-19 pandemic where Shopify had to help companies migrate online.

“Our job is no matter what comes the way of our merchants, we provide them with tools and service and support for them to navigate it really well,” he said.

Finkelstein was questioned about the forthcoming U.S. leadership change on a call meant to delve into Shopify’s latest earnings, which sent shares soaring 27 per cent to $158.63 shortly after Tuesday’s market open.

The Ottawa-based company, which keeps its books in U.S. dollars, reported US$828 million in net income for its third quarter, up from US$718 million in the same quarter last year, as its revenue rose 26 per cent.

Revenue for the period ended Sept. 30 totalled US$2.16 billion, up from US$1.71 billion a year earlier.

Subscription solutions revenue reached US$610 million, up from US$486 million in the same quarter last year.

Merchant solutions revenue amounted to US$1.55 billion, up from US$1.23 billion.

Shopify’s net income excluding the impact of equity investments totalled US$344 million for the quarter, up from US$173 million in the same quarter last year.

Daniel Chan, a TD Cowen analyst, said the results show Shopify has a leadership position in the e-commerce world and “a continued ability to gain market share.”

In its outlook for its fourth quarter of 2024, the company said it expects revenue to grow at a mid-to-high-twenties percentage rate on a year-over-year basis.

“Q4 guidance suggests Shopify will finish the year strong, with better-than-expected revenue growth and operating margin,” Chan pointed out in a note to investors.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:SHOP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

RioCan cuts nearly 10 per cent staff in efficiency push as condo market slows

Published

 on

 

TORONTO – RioCan Real Estate Investment Trust says it has cut almost 10 per cent of its staff as it deals with a slowdown in the condo market and overall pushes for greater efficiency.

The company says the cuts, which amount to around 60 employees based on its last annual filing, will mean about $9 million in restructuring charges and should translate to about $8 million in annualized cash savings.

The job cuts come as RioCan and others scale back condo development plans as the market softens, but chief executive Jonathan Gitlin says the reductions were from a companywide efficiency effort.

RioCan says it doesn’t plan to start any new construction of mixed-use properties this year and well into 2025 as it adjusts to the shifting market demand.

The company reported a net income of $96.9 million in the third quarter, up from a loss of $73.5 million last year, as it saw a $159 million boost from a favourable change in the fair value of investment properties.

RioCan reported what it says is a record-breaking 97.8 per cent occupancy rate in the quarter including retail committed occupancy of 98.6 per cent.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:REI.UN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending